Gene · 51673
Papers1,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection. | Sci Adv | 2022 | 36103544 | PubTator, text mining | PubMed |
| Proteomic study of facial melasma. | An Bras Dermatol | 2022 | 36100478 | PubTator, text mining | PubMed |
| Pyroptosis in periodontitis: From the intricate interaction with apoptosis, NETosis, and necroptosis to the therapeutic prospects. | Front Cell Infect Microbiol | 2022 | 36093182 | PubTator, text mining | PubMed |
| The interplay between serine proteases and caspase-1 regulates the autophagy-mediated secretion of Interleukin-1 beta in human neutrophils. | Front Immunol | 2022 | 36091026 | PubTator, text mining | PubMed |
| PSMB5 Alleviates Ulcerative Colitis by Inhibiting ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis. | Dis Markers | 2022 | 36061354 | PubTator, text mining | PubMed |
| Occult infection with hepatitis B virus PreS variants synergistically promotes hepatocellular carcinoma development in a high-fat diet context by generating abnormal ceramides. | BMC Med | 2022 | 36058909 | PubTator, text mining | PubMed |
| The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma. | Arch Oral Biol | 2022 | 36058091 | PubTator, text mining | PubMed |
| Challenges and perspectives of tendon-derived cell therapy for tendinopathy: from bench to bedside. | Stem Cell Res Ther | 2022 | 36056395 | PubTator, text mining | PubMed |
| Z1456467176 alleviates gouty arthritis by allosterically modulating P2X7R to inhibit NLRP3 inflammasome activation. | Front Pharmacol | 2022 | 36052144 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the cellular and molecular changes that contribute to the progression of lung adenocarcinoma. | Front Cell Dev Biol | 2022 | 36046337 | PubTator, text mining | PubMed |
| Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1β axes bridge innate immunity and epithelial apoptosis to promote emphysema. | Proc Natl Acad Sci U S A | 2022 | 36037355 | PubTator, text mining | PubMed |
| The role of NPC1L1 in cancer. | Front Pharmacol | 2022 | 36034854 | PubTator, text mining | PubMed |
| Echovirus 11 infection induces pyroptotic cell death by facilitating NLRP3 inflammasome activation. | PLoS Pathog | 2022 | 36026486 | PubTator, text mining | PubMed |
| Outer membrane vesicles of Porphyromonas gingivalis trigger NLRP3 inflammasome and induce neuroinflammation, tau phosphorylation, and memory dysfunction in mice. | Front Cell Infect Microbiol | 2022 | 36017373 | PubTator, text mining | PubMed |
| Flaviviridae Nonstructural Proteins: The Role in Molecular Mechanisms of Triggering Inflammation. | Viruses | 2022 | 36016430 | PubTator, text mining | PubMed |
| Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing. | Vaccines (Basel) | 2022 | 36016137 | PubTator, text mining | PubMed |
| Macrophage Polarization Mediated by Mitochondrial Dysfunction Induces Adipose Tissue Inflammation in Obesity. | Int J Mol Sci | 2022 | 36012516 | PubTator, text mining | PubMed |
| Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis. | Biomedicines | 2022 | 36009355 | PubTator, text mining | PubMed |
| Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance. | J Immunother Cancer | 2022 | 36002186 | PubTator, text mining | PubMed |
| The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic. | Pharmacol Rep | 2022 | 35997950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51673/papers?page=18